Enhanced hepatic drug clearance in patients with cystic fibrosis
- 1 December 1990
- journal article
- research article
- Published by Elsevier in The Journal of Pediatrics
- Vol. 117 (6) , 972-979
- https://doi.org/10.1016/s0022-3476(05)80149-0
Abstract
No abstract availableThis publication has 54 references indexed in Scilit:
- Lorazepam pharmacodynamics and pharmacokinetics in childrenThe Journal of Pediatrics, 1989
- The P450 Gene Superfamily: Recommended NomenclatureDNA, 1987
- Introduction to pharmacokinetics: Aminoglycosides in cystic fibrosis as a prototypeThe Journal of Pediatrics, 1986
- Cloxacillin absorption and disposition in cystic fibrosisThe Journal of Pediatrics, 1984
- Disposition of tobramycin in patients with cystic fibrosis: A prospective controlled studyThe Journal of Pediatrics, 1984
- Dosing implications of altered gentamicin disposition in patients with cystic fibrosisThe Journal of Pediatrics, 1982
- Clinical Pharmacokinetics of FrusemideClinical Pharmacokinetics, 1979
- Hepatic changes in young infants with cystic fibrosis: Possible relation to focal biliary cirrhosisThe Journal of Pediatrics, 1975
- A new prognostic score and clinical evaluation system for cystic fibrosisThe Journal of Pediatrics, 1973
- The effects of age on alkaline phosphatase and other serologic liver function tests in normal subjects and patients with cystic fibrosisThe Journal of Pediatrics, 1973